NCT03306810 (AGS) is a NA clinical trial of AG service in Dysglycemia, sponsored by Joint Authority for Päijät-Häme Social and Health Care.

Who is sponsoring NCT03306810?

NCT03306810 is sponsored by Joint Authority for Päijät-Häme Social and Health Care.

What drugs are being tested in NCT03306810?

Interventions in NCT03306810: AG service.

What condition does NCT03306810 study?

NCT03306810 studies Dysglycemia, Arthroplasty Complications.

Is NCT03306810 still recruiting?

NCT03306810 is currently status unknown. Last updated 11 October 2017.

Last reviewed 2017-10-11 · How we verify

NCT03306810: AGS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Recognition and Treatment of Dysglycemia. AGS - Acute Glucose Service

Status unknown NA Last updated 11 October 2017

What this trial tests

NA trial testing AG service in Dysglycemia in 600 participants. Status unknown.

Timeline

26 September 2017

Primary endpoint
31 December 2019

31 December 2025

Quick facts

Lead sponsor	Joint Authority for Päijät-Häme Social and Health Care
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	600
Start date	26 September 2017
Primary completion	31 December 2019
Estimated completion	31 December 2025
Sites	1 location across Finland

Drugs / interventions tested

AG service

Conditions studied

Dysglycemia — all drugs for Dysglycemia →
Arthroplasty Complications — all drugs for Arthroplasty Complications →

Sponsor

Joint Authority for Päijät-Häme Social and Health Care — full company profile →

Who can join

18 and older, any sex, with Dysglycemia or Arthroplasty Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

AGS (Acute Glucose Service ) is an inpatient glucose management service consisting of Nurse Practitioner and physician. Team manages not - consulted- based preoperative assessment, perioperative glucose control, patient education and supervision, but also transition of care postoperatively. The goal is to detect and treat dysglycemias , but also provide an active and constantly ongoing education to other hospital teams. AGS improves better overall- survival of arthroplastic patients and is an effective way to recognize and treat dysglycemias and to organize constantly ongoing education.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Perioperative hyperglycaemia in elective arthroplasties. Should we do better?
Ylikoski M, Jokinen JJ, Lahtela J, Kauppi MJ, et al · · 2020 · cited 2× · PMID 32615649 · DOI 10.1111/aas.13666

Verify or expand the search:

Other recruiting trials for Dysglycemia

Currently open trials in the same condition.

NCT07263789 — Effect of a Food Supplement on Blood Glucose Levels in Patients With Impaired Glucose Values · NA · recruiting
NCT06314061 — The Effect of Continuous Glucose Monitoring in Surgical Patients With Diabetes. · Phase 4 · recruiting
NCT06297850 — Accuracy of Continuous Glucose Monitoring in Patients With Diabetes. A Prospective Observational Study · active not recruiting
NCT06050265 — Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary Syndrome · NA · active not recruiting
NCT05852054 — Supporting Transitions to Primary Care Among Under-resourced, Postpartum Women (STEP-UP) · Phase 3 · active not recruiting

Other Joint Authority for Päijät-Häme Social and Health Care trials

Trials by the same sponsor.

NCT06633146 — Stroke Rehabilitation Utilizing Therapeutical Methods Designed for Nature Environments · NA · recruiting
NCT05898542 — Nature-based Therapies in Stroke Rehabilitation · NA · recruiting
NCT05005117 — Laparoscopic Approach for Emergency Colon Resection · NA · recruiting
NCT04564105 — Simulation Training and Teamwork Concerning Intubation on the Icu · NA · completed
NCT05025319 — Optimization of Bedside Chest X-rays Taken in the Intensive Care Unit by Using Current Software-based Techniques · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03306810 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Joint Authority for Päijät-Häme Social and Health Care
Last refreshed: 11 October 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03306810.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing